[Immunogenicity, safety and immune persistence of the sequential booster with the recombinant protein-based COVID-19 vaccine (CHO cell) in healthy people aged 18-84 years].
Yao DY, Chen YP, Ding F, Hu XS, Liang ZZ, Xing B, Cao YF, Zhang TQ, Wang XL, Liao YT, Yang J, Lyu HK.
Yao DY, et al.
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Jan 6;58(1):25-32. doi: 10.3760/cma.j.cn112150-20230423-00317.
Zhonghua Yu Fang Yi Xue Za Zhi. 2024.
PMID: 38228546
Chinese.
The eligible healthy individuals, aged 18-84 years who had completed primary immunization with the inactivated COVID-19 vaccine 3 to 9 months before, were recruited from Shangyu district of Shaoxing and Kaihua county of Quzhou, Zhejiang province. All participants were divi …
The eligible healthy individuals, aged 18-84 years who had completed primary immunization with the inactivated COVID-19 vaccine 3 to 9 month …